PUBLISHER: DataM Intelligence | PRODUCT CODE: 1156072
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1156072
Oxaliplatin Market Size, Competitive Landscape and Market Forecast - 2029
Market Overview
The global Oxaliplatin market size was valued US$ XX billion in 2022 and is estimated to reach US$ XX billion by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).
Oxaliplatin is an anti-cancer medication indicated to treat colorectal cancer. It is a platinum-based drug belonging to the same family as that of cisplatin and carboplatin. Oxaliplatin acts by interfering with the development of DNA in a cell, thereby stopping it from dividing into new cells and kills it.
Oxaliplatin Market Dynamics
The oxaliplatin market growth is driven by the growing incidence of Colorectal cancers, and changing lifestyle, increasing geriatric population and extensive research in field of oncology are the major factors that are anticipated to boost the global oxaliplatin market during the forecast period.
Increasing incidence of Colorectal Cancers, is expected to drive the global oxaliplatin market during the forecast period.
The number of colorectal cancer cases worldwide has been increasing. As per the American Cancer Society (ACS) estimates, there will be around 101,420 new colon cancer cases, and around 44,180 new cases of rectal cancer are registered in the USA in 2019. As per the National Cancer Institute data, nearly 1,735,350 new cases of cancer were diagnosed in the U.K in 2018. The diagnosed incident colorectal cancer cases are expected to increase by 27.3% to 672,400 cases by 2037. This increase can be attributed to a low-fiber diet, obesity, alcohol, and tobacco consumption. The increase in the number of colorectal cases will add to the overall global oxaliplatin market.
Increased usage of biologics and targeted therapies is likely to hamper the global colorectal cancer drugs market.
Increased usage of biologics and targeted therapies is likely to hamper the market growth. Biologic therapy helps the body's immune system fight against cancer rather than chemical drugs, which reduces the body's immune power. Targeted therapies block the growth and spreading of colorectal cancer even in stage IV, where chemical drugs are ineffective. For instance, the FDA has approved some targeted therapies to treat colorectal cancer, including bevacizumab, cetuximab, and panitumumab. The advantages of biologics drugs and targeted therapies over conventional chemical drugs might negatively influence the market.
COVID-19 Impact Analysis
Due to the covid-19 pandemic outbreak, the market for global oxaliplatin market was seen to be down, due to the barriers in production and sales segments. Since the outbreak led to the shutdown of all manufacturing firms except for masks, sanitizers and ventilators. Hence, the drugs were manufactured less compared to previous years, during the outbreak.
Segment Analysis
The lyophilized powder segment is expected to hold largest share in this market segment
Lyophilization is a freeze-drying process, which is performed to extend the shelf life of a product. The oxaliplatin lyophilized powder injection is prepared using a specific lyophilization process to increase the stability of the drug, reduce the risk of side effects, and ensure a high degree of clinical usage. However, it is slightly expensive than the aqueous solution. The global average selling price of 100 mg intravenous injection is around USD 84 - USD 500. Sanofi offers ELOXATIN in a lyophilized powder form.
The adjuvant treatment of stage III colon cancer segment is expected to hold largest share in this market segment
In patients with stage III colon cancer, adjuvant chemotherapy with fluoropyrimidine combined with oxaliplatin (FOLFOX and XELOX) are considered the standard treatment and reduces the risk of recurrence and mortality, with a treatment duration that may be shortened from 6 to 3 months in certain situations allowing to limit toxicities, especially cumulative sensitive neuropathy.
The colorectal cancer segment is expected to hold largest share in this market segment
Colorectal cancer is the second leading cause of cancer deaths in the U.S. As per the data by the National Cancer Institute, nearly 1,735,350 new cases of cancer were diagnosed in the U.K. and 609,640 people were succumbed to the disease in 2018. According to the American Society of Clinical Oncology (ASCO), in 2019, nearly 45,600 adults in the U.S. were diagnosed with colorectal cancer.
The hospital pharmacies segment is expected to hold largest share in this market segment
The hospital pharmacies held the largest share in the global oxaliplatin market. This is mainly owing to increasing number of patients suffering from colorectal cancers which are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, Increasing number of oncologists and healthcare professionals, specializing in the diagnosis of cancer at an early stage and providing proper treatment is also contributing to the growth of this segment.Also the medications can only be administrated by intravenously under supervision of medical practioners at these locations.
Geographical Analysis
North America region holds the largest market share of global oxaliplatin market
North America held a major share of the global oxaliplatin market and is expected to continue its dominance during the forecast period. In North America, the oxaliplatin market is projected to be driven by an increase in colorectal cancer cases and raising awareness of various treatment modalities for cancer. As per the U.S. Department of Health and Human Services in U.S., colorectal cancer represented 8.3% of all new cancer cases in 2019. According to the American Cancer Society, Inc. (ACS), in 2020, nearly 104,610 new colon and 43,340 cases of rectal cancer are expected to be diagnosed in the U.S., with nearly 53,200 deaths from colorectal cancer.
Competitive Landscape
The global oxaliplatin market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include Sanofi, Pfizer Inc, Fresenius Kabi D, Dr. Reddy's laboratory, Sun Pharmaceutical Industries Ltd, Qilu Pharmaceutical Co., Ltd, Teva Pharmaceuticals USA, Inc, Jiangsu Aosaikang Pharmaceutical Co. Ltd, Mylan, Hospira, Nanjing Phamaceutical Factory, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hisun Pharmaceutical, Hainan Jinrui Pharmaceutical. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally.
Oxaliplatin Market Key Companies to Watch:
Pfizer Inc.
- Overview: Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines that improve patients' lives. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology and rare diseases. EH includes legacy brands, branded generics, generic sterile injectable products, and biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. The Company sold its products in over 125 countries.
- Product Portfolio: The Company's portfolio comprised of include internal medicine, vaccines, oncology, inflammation and immunology and rare diseases and others.
- Product: OXALIPLATIN injection, for intravenous use 50 mg (5 mg/mL) or 100 mg (5 mg/mL) in a single-dose vial for adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor and treatment of advanced colorectal cancer.
Why Purchase the Report?
- Visualize the composition of the oxaliplatin market segmentation by formulation type, application, indication, distribution channel and by region highlighting the key commercial assets and players.
- Identify commercial opportunities in oxaliplatin market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of oxaliplatin market - level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global oxaliplatin market report would provide an access to an approx. 69 market data table, 61 figures and 200 pages.
Target Audience
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
Table of Contents
1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
- 3.1. Market Snippet by Formulation Type
- 3.2. Market Snippet by Indication
- 3.3. Market Snippet by Application
- 3.4. Market Snippet by Distribution channel
- 3.5. Market Snippet by Region
4. Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Driver
- 4.1.1.1. Increasing incidence of Colorectal Cancers
- 4.1.2. Restraints:
- 4.1.2.1. Increased usage of biologics and targeted therapies
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 4.1.1. Driver
5. Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. PEST Analysis
- 5.3. Supply Chain Analysis
- 5.4. Pricing Analysis
- 5.5. Regulatory Analysis
- 5.6. Reimbursement Analysis
- 5.7. Unmet Needs
6. COVID-19 Analysis
- 6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
- 6.2. Pricing Dynamics Amid Covid-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
7. By Formulation Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation type Segment
- 7.1.2. Market Attractiveness Index, By Formulation type Segment
- 7.2. Lyophilized Powder*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
- 7.3. Aqueous Solutions
8. By Indication
- 8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication Segment
- 8.1.2. Market Attractiveness Index, By Indication Segment
- 8.2. Adjuvant Treatment of Stage III Colon Cancer*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
- 8.3. Treatment of Stage IV Colorectal Cancer
- 8.4. Others
9. By Application
- 9.1. Introduction
- 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
- 9.2. Colorectal Cancer*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
- 9.3. Stomach cancer
- 9.4. Ovarian cancer
10. By Distribution Channel
- 10.1. Introduction
- 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel
- 10.1.2. Market Attractiveness Index, By Distribution channel
- 10.2. Hospital Pharmacies*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
- 10.3. Retail Pharmacies
- 10.4. Online Pharmacies
11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation Type
- 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
- 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.2.7.1. U.S.
- 11.2.7.2. Canada
- 11.2.7.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation Type
- 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
- 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.3.7.1. Germany
- 11.3.7.2. U.K.
- 11.3.7.3. France
- 11.3.7.4. Italy
- 11.3.7.5. Spain
- 11.3.7.6. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation Type
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. Brazil
- 11.4.7.2. Argentina
- 11.4.7.3. Rest of South America
- 11.5. Asia Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation Type
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.5.7.1. China
- 11.5.7.2. India
- 11.5.7.3. Japan
- 11.5.7.4. Australia
- 11.5.7.5. Rest of Asia Pacific
- 11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation Type
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
12. Competitive Landscape
- 12.1. Key Developments and Strategies
- 12.2. Company Share Analysis
- 12.3. Product Benchmarking
- 12.4. Key Companies to Watch
- 12.5. Company with disruptive technology
- 12.6. Start Up Companies
13. Global Oxaliplatin Market - Company Profiles
- 13.1. Pfizer Inc*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
- 13.2. Sanofi
- 13.3. Fresenius Kabi D
- 13.4. Dr. Reddy's laboratory
- 13.5. Sun Pharmaceutical Industries Ltd
- 13.6. Qilu Pharmaceutical Co., Ltd
- 13.7. Teva Pharmaceuticals USA, Inc
- 13.8. Jiangsu Aosaikang Pharmaceutical Co. Ltd
- 13.9. Mylan
- 13.10. Hospira
- 13.11. Nanjing Phamaceutical Factory
- 13.12. Jiangsu Hengrui Medicine
- 13.13. Lunan Pharmaceutical
- 13.14. Hisun Pharmaceutical
- 13.15. Hainan Jinrui Pharmaceutical
*(LIST NOT EXHAUSTIVE)
14. DataM Intelligence
- 14.1. Appendix
- 14.2. About Us and Services
- 4.3. Contact Us
List of Tables
- Table 1: Global Oxaliplatin Market Value, By Formulation Type, 2021,2025 & 2029($ Million)
- Table 2: Global Oxaliplatin Market Value, By Application, 2021,2025 & 2029($ Million)
- Table 3: Global Oxaliplatin Market Value, By Indication, 2021,2025 & 2029($ Million)
- Table 4: Global Oxaliplatin Market Value, By Distribution Channel, 2021,2025 & 2029($ Million)
- Table 5: Global Oxaliplatin Market Value, By Region, 2021,2025 & 2029($ Million)
- Table 6: Global Oxaliplatin Market Value, By Formulation Type, 2021,2025 & 2029($ Million)
- Table 7: Global Oxaliplatin Market Value, By Formulation Type, 2018-2029($ Million)
- Table 8: Global Oxaliplatin Market Value, By Application, 2021,2025 & 2029($ Million)
- Table 9: Global Oxaliplatin Market Value, By Application, 2018-2029($ Million)
- Table 10: Global Oxaliplatin Market Value, By Indication, 2021,2025 & 2029($ Million)
- Table 11: Global Oxaliplatin Market Value, By Indication, 2018-2029($ Million)
- Table 12: Global Oxaliplatin Market Value, By Distribution Channel, 2021,2025 & 2029($ Million)
- Table 13: Global Oxaliplatin Market Value, By Distribution Channel, 2018-2029($ Million)
- Table 14: Global Oxaliplatin Market Value, By Region, 2021,2025 & 2029($ Million)
- Table 15: Global Oxaliplatin Market Value, By Region, 2018-2029($ Million)
- Table 16: North America Oxaliplatin Market Value, By Formulation Type, 2018-2029($ Million)
- Table 17: North America Oxaliplatin Market Value, By Application, 2018-2029($ Million)
- Table 18: North America Oxaliplatin Market Value, By Indication, 2018-2029($ Million)
- Table 19: North America Oxaliplatin Market Value, By Distribution Channel, 2018-2029($ Million)
- Table 20: North America Oxaliplatin Market Value, By Country, 2018-2029($ Million)
- Table 21: South America Oxaliplatin Market Value, By Formulation Type, 2018-2029($ Million)
- Table 22: South America Oxaliplatin Market Value, By Application, 2018-2029($ Million)
- Table 23: South America Oxaliplatin Market Value, By Indication, 2018-2029($ Million)
- Table 24: South America Oxaliplatin Market Value, By Distribution Channel, 2018-2029($ Million)
- Table 25: South America Oxaliplatin Market Value, By Country, 2018-2029($ Million)
- Table 26: Europe Oxaliplatin Market Value, By Formulation Type, 2018-2029($ Million)
- Table 27: Europe Oxaliplatin Market Value, By Application, 2018-2029($ Million)
- Table 28: Europe Oxaliplatin Market Value, By Indication, 2018-2029($ Million)
- Table 29: Europe Oxaliplatin Market Value, By Distribution Channel, 2018-2029($ Million)
- Table 30: Europe Oxaliplatin Market Value, By Country, 2018-2029($ Million)
- Table 31: Asia-Pacific Oxaliplatin Market Value, By Formulation Type, 2018-2029($ Million)
- Table 32: Asia-Pacific Oxaliplatin Market Value, By Application, 2018-2029($ Million)
- Table 33: Asia-Pacific Oxaliplatin Market Value, By Indication, 2018-2029($ Million)
- Table 34: Asia-Pacific Oxaliplatin Market Value, By Distribution Channel, 2018-2029($ Million)
- Table 35: Asia-Pacific Oxaliplatin Market Value, By Country, 2018-2029($ Million)
- Table 36: Middle East & Africa Oxaliplatin Market Value, By Formulation Type, 2018-2029($ Million)
- Table 37: Middle East & Africa Oxaliplatin Market Value, By Application, 2018-2029($ Million)
- Table 38: Middle East & Africa Oxaliplatin Market Value, By Indication, 2018-2029($ Million)
- Table 39: Middle East & Africa Oxaliplatin Market Value, By Distribution Channel, 2018-2029($ Million)
- Table 40: Pfizer Inc: Overview
- Table 41: Pfizer Inc: Product Portfolio
- Table 42: Pfizer Inc: Key Developments
- Table 43: Fresenius Kabi D: Overview
- Table 44: Fresenius Kabi D: Product Portfolio
- Table 45: Fresenius Kabi D: Key Developments
- Table 46: Sanofi: Overview
- Table 47: Sanofi: Product Portfolio
- Table 48: Sanofi: Key Developments
- Table 49: Dr. Reddy's laboratory: Overview
- Table 50: Dr. Reddy's laboratory: Product Portfolio
- Table 51: Dr. Reddy's laboratory: Key Developments
- Table 52: Sun Pharmaceutical Industries Ltd: Overview
- Table 53: Sun Pharmaceutical Industries Ltd: Product Portfolio
- Table 54: Sun Pharmaceutical Industries Ltd: Key Developments
- Table 55: Qilu Pharmaceutical Co., Ltd: Overview
- Table 56: Qilu Pharmaceutical Co., Ltd: Product Portfolio
- Table 57: Qilu Pharmaceutical Co., Ltd: Key Developments
- Table 58: Teva Pharmaceuticals USA, Inc: Overview
- Table 59: Teva Pharmaceuticals USA, Inc: Product Portfolio
- Table 60: Teva Pharmaceuticals USA, Inc: Key Developments
- Table 61: Jiangsu Aosaikang Pharmaceutical Co. Ltd: Overview
- Table 62: Jiangsu Aosaikang Pharmaceutical Co. Ltd: Product Portfolio
- Table 63: Jiangsu Aosaikang Pharmaceutical Co. Ltd: Key Developments
- Table 64: Mylan: Overview
- Table 65: Mylan: Product Portfolio
- Table 66: Mylan: Key Developments
- Table 67: Hospira: Overview
- Table 68: Hospira: Product Portfolio
- Table 69: Hospira: Key Developments
List of Figures
- Figure 1: Global Oxaliplatin Market Share, By Formulation Type, 2021 & 2029(%)
- Figure 2: Global Oxaliplatin Market Share, By Application, 2021 & 2029(%)
- Figure 3: Global Oxaliplatin Market Share, By Indication, 2021 & 2029(%)
- Figure 4: Global Oxaliplatin Market Share, By Distribution Channel, 2021 & 2029(%)
- Figure 5: Global Oxaliplatin Market Share, By Region, 2021 & 2029(%)
- Figure 6: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 7: Global Oxaliplatin Market Y-o-Y Growth, By Formulation Type, 2021 & 2029(%)
- Figure 8: Lyophilized Powder: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 9: Aqueous Solutions: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 10: Global Oxaliplatin Market Y-o-Y Growth, By Application, 2021 & 2029(%)
- Figure 11: Colorectal cancer: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 12: Stomach Cancer: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 13: Ovarian Cancer: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 14: Global Oxaliplatin Market Y-o-Y Growth, By Indication, 2021 & 2029(%)
- Figure 15: Adjuvant Treatment of Stage III Colon Cancer: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 16: Treatment of Stage IV Colorectal Cancer: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 17: Others: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 18: Global Oxaliplatin Market Y-o-Y Growth, By Distribution Channel, 2021 & 2029(%)
- Figure 19: Hospital Pharmacies: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 20: Retail Pharmacies: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 21: Online Pharmacies: Global Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 22: Global Oxaliplatin Market Y-o-Y Growth, By Region, 2021 & 2029(%)
- Figure 23: North America Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 24: North America Oxaliplatin Market Share, By Formulation Type, 2021 & 2029(%)
- Figure 25: North America Oxaliplatin Market Share, By Application, 2021 & 2029(%)
- Figure 26: North America Oxaliplatin Market Share, By Indication, 2021 & 2029(%)
- Figure 27: North America Oxaliplatin Market Share, By Distribution Channel, 2021 & 2029(%)
- Figure 28: North America Oxaliplatin Market Share, By Country, 2021 & 2029(%)
- Figure 29: South America Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 30: South America Oxaliplatin Market Share, By Formulation Type, 2021 & 2029(%)
- Figure 31: South America Oxaliplatin Market Share, By Application, 2021 & 2029(%)
- Figure 32: South America Oxaliplatin Market Share, By Indication, 2021 & 2029(%)
- Figure 33: South America Oxaliplatin Market Share, By Distribution Channel, 2021 & 2029(%)
- Figure 34: South America Oxaliplatin Market Share, By Country, 2021 & 2029(%)
- Figure 35: Europe Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 36: Europe Oxaliplatin Market Share, By Formulation Type, 2021 & 2029(%)
- Figure 37: Europe Oxaliplatin Market Share, By Application, 2021 & 2029(%)
- Figure 38: Europe Oxaliplatin Market Share, By Indication, 2021 & 2029(%)
- Figure 39: Europe Oxaliplatin Market Share, By Distribution Channel, 2021 & 2029(%)
- Figure 40: Europe Oxaliplatin Market Share, By Country, 2021 & 2029(%)
- Figure 41: Asia-Pacific Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 42: Asia-Pacific Oxaliplatin Market Share, By Formulation Type, 2021 & 2029(%)
- Figure 43: Asia-Pacific Oxaliplatin Market Share, By Application, 2021 & 2029(%)
- Figure 44: Asia-Pacific Oxaliplatin Market Share, By Indication, 2021 & 2029(%)
- Figure 45: Asia-Pacific Oxaliplatin Market Share, By Distribution Channel, 2021 & 2029(%)
- Figure 46: Asia-Pacific Oxaliplatin Market Share, By Country, 2021 & 2029(%)
- Figure 47: Middle East & Africa Oxaliplatin Market Value, 2018-2029($ Million)
- Figure 48: Middle East & Africa Oxaliplatin Market Share, By Formulation Type, 2021 & 2029(%)
- Figure 49: Middle East & Africa Oxaliplatin Market Share, By Application, 2021 & 2029(%)
- Figure 50: Middle East & Africa Oxaliplatin Market Share, By Indication, 2021 & 2029(%)
- Figure 51: Middle East & Africa Oxaliplatin Market Share, By Distribution Channel, 2021 & 2029(%)
- Figure 52: Pfizer Inc: Financials
- Figure 53: Fresenius Kabi D: Financials
- Figure 54: Sanofi: Financials
- Figure 55: Dr. Reddy's laboratory: Financials
- Figure 56: Sun Pharmaceutical Industries Ltd: Financials
- Figure 57: Qilu Pharmaceutical Co., Ltd: Financials
- Figure 58: Teva Pharmaceuticals USA, Inc: Financials
- Figure 59: Jiangsu Aosaikang Pharmaceutical Co. Ltd: Financials
- Figure 60: Mylan: Financials
- Figure 61: Hospira: Financials
